跳至主要内容
临床试验/ACTRN12612001098820
ACTRN12612001098820已完成未知

Prospective, controlled, open label, bilateral, clinical trial to investigate daily, morning cleaning of silicone hydrogel contact lenses worn during extended wear as a strategy for reducing adverse events associated with contact lens wear in neophyte and experienced lens wearers

Brien Holden Vision Institute0 个研究点目标入组 200 人开始时间: 2012年10月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent.
  • -Be at least 18 years old, male or female.
  • -Be willing to comply with the wearing and clinical trial visit schedule as directed by the Investigator.
  • -Have ocular health findings considered to be normal” and which would not prevent the participant from safely wearing contact lenses.
  • -Have vision that is correctable to at least 6/12 (20/40) or better in each eye with contact lenses/spectacles.
  • -Be experienced or inexperienced at wearing contact lenses.

排除标准

  • -Any pre-existing ocular irritation, injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses;
  • -Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosis. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants;
  • -An active corneal infection or any active ocular disease that would affect wearing of contact lenses;
  • -Use of or a need for any therapeutic ocular medication up to 4 weeks prior to and during the trial;
  • -Use of or a need for any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant’s ocular health/physiology or contact lens performance either in an adverse manner or risk providing a false positive.
  • -Eye surgery within 12 weeks immediately prior to enrolment for this trial.
  • -Previous corneal refractive surgery.
  • -Contraindications to contact lens wear.
  • -Known allergy or intolerance to ingredients in any of the clinical trial products.
  • -Currently enrolled in another clinical trial.

研究者

发起方
Brien Holden Vision Institute

相似试验